Reproductive signaling
Used for HPG-axis information involving GnRH, LH, FSH, and downstream sex-hormone signaling.
Back to peptide library
Reproductive hormone signaling
Kisspeptin
Kisspeptin is used as part of clinician-guided planning for HPG-axis support, reproductive hormone signaling, libido, fertility planning, and hormone-balance information.
HPG axis supportGnRH signaling pathwayHormone balance focusClinical screening required
Overview
What is Kisspeptin?
Kisspeptin is a naturally occurring neuropeptide involved in the hypothalamic-pituitary-gonadal axis. It signals through the KISS1 receptor and helps stimulate GnRH, which then influences LH and FSH release.
IPS reviews Kisspeptin in context: reproductive goals, libido, menstrual or ovulatory history, testosterone or estrogen concerns, fertility planning, metabolic health, medications, and whether hormone testing or specialist care is needed.
Common program goals
- Review reproductive hormone signaling and HPG-axis support
- Review fertility, libido, cycle, testosterone, or estrogen concerns
- Screen medications, hormone history, and contraindications
- Coordinate with fertility, hormone, primary-care, or specialist care when needed
- Track symptoms, labs when appropriate, and clinical response over time
Who it may fit
Kisspeptin is on the IPS clinical program.
IPS includes Kisspeptin as a clinician-guided option. Clinical details are reviewed during consultation.
Fertility and libido context
May be reviewed when reproductive wellness, libido, ovulatory function, or hormonal balance are part of the goal.
Testing and monitoring
Hormone labs, symptom history, fertility plans, and medication use help determine candidacy.
How It Works
Why Kisspeptin is used as part of clinician-guided planning for hormone signaling.
Kisspeptin is used for GnRH stimulation and downstream LH and FSH signaling. IPS keeps the review tied to physiology, lab context, and whether this pathway fits the person's goals and medical history.
GnRH pathway
Kisspeptin helps signal GnRH neurons, which influence reproductive hormone cascades.
LH and FSH
These pituitary signals are part of ovulation, spermatogenesis, testosterone production, and estrogen signaling.
Libido and fertility
Some patients ask about Kisspeptin for libido, fertility support, cycle concerns, or hormone optimization.
Metabolic context
The reference page also reviewes metabolic signaling, so blood sugar, weight, and energy context may matter.
Process
How Kisspeptin care works at IPS.
Hormone Review
Review reproductive goals, libido, cycle or fertility history, testosterone or estrogen concerns, and current therapies.
Clinical Screening
Screen pregnancy-related factors, fertility care, hormone-sensitive conditions, medications, and lab needs.
Protocol Design
If appropriate, your clinician reviews candidacy, planning, monitoring, expectations, and how it fits the broader plan.
Follow-Up
Follow-up tracks tolerance, symptoms, hormone markers when appropriate, and whether adjustments are needed.
Safety & candidacy
Hormone-axis protocols need careful review.
IPS reviews fertility goals, hormone-sensitive conditions, pregnancy-related factors where applicable, medication use, endocrine diagnoses, cancer history, and whether specialist involvement is needed before considering Kisspeptin.
Common effectsInjection-site irritation, headache, nausea, mood shifts, libido changes, or hormone-related symptom changes may occur.
TestingBaseline and follow-up hormone labs may be appropriate depending on goals and clinical context.
Medication reviewHormone therapy, fertility medications, psychiatric medications, diabetes medications, and supplements should be disclosed.
No guaranteesResponse varies, and Kisspeptin is not intended to diagnose, treat, cure, or prevent disease.
Questions
Frequently asked.
How does IPS evaluate Kisspeptin?
Yes. Kisspeptin is in the IPS clinical program. Clinical details are reviewed during consultation.
What does Kisspeptin support?
It is framed around HPG-axis signaling, GnRH activity, reproductive hormone balance, libido, and fertility-related information.
Can it replace fertility or hormone care?
No. Fertility, endocrine, and hormone concerns should be evaluated and managed by the appropriate clinician.
Who needs careful screening?
People using hormone therapy or fertility medications, people with hormone-sensitive conditions, and anyone with pregnancy-related factors or complex endocrine history need careful review.
Why IPS is different
Not gray market. Not research-only. Not direct-to-consumer peptide kits.
Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.
RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS
Products marketed online
- May be labeled research use only
- May be labeled not for human consumption
- May be marketed as laboratory chemicals
- May not include patient-specific documentation
- May not involve provider review
The IPS approach
- Consultation before recommendation
- Provider review
- Personalized recommendations
- Medical oversight
- Ongoing guidance and support
Important distinction
A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.
Annual Membership
Wholesale-Style Member Pricing
12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.
12-month membership requiredMember pricing reviewed during consultClinical review before any plan
Ask About Membership PricingContact
Ask IPS about Kisspeptin eligibility.
Send your details and IPS can follow up about consultation scheduling and next steps.
Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require qualified clinical care.